Ribolac

Ribolac Uses, Dosage, Side Effects, Food Interaction and all others data.

Ribolac is a non-aminoglycoside semi-synthetic antibacterial derived from rifamycin SV. It inhibits bacterial RNA synthesis by binding to the bacterial DNA-dependent RNA polymerase and has antibacterial activity against Escherichia coli (E. coli).

Ribolac is a structural analog of rifampin and a non-systemic, gastrointestinal site-specific antibiotic. This non-systemic property of the drug is due to the addition of a pyridoimidazole ring, which renders it non-absorbable. Ribolac acts by inhibiting bacterial ribonucleic acid (RNA) synthesis and contributes to restore intestinal microflora imbalance. Other studies have also shown rifaximin to be an pregnane X receptor (PXR) activator. As PXR is responsible for inhibiting the proinflammatory transcription factor NF-kappa B (NF-κB) and is inhibited in inflammatory bowel disease (IBD), rifaximin was proven to be effective for the treatment of IBS-D.

Trade Name Ribolac
Availability Prescription only
Generic Rifaximin
Rifaximin Other Names Rifaxidin, Rifaximin, Rifaximina, Rifaximine, Rifaximinun
Related Drugs ciprofloxacin, dicyclomine, sulfamethoxazole / trimethoprim, Bactrim, loperamide, lactulose, Bentyl, hyoscyamine, Xifaxan, Imodium
Type
Formula C43H51N3O11
Weight Average: 785.8785
Monoisotopic: 785.352359489
Groups Approved, Investigational
Therapeutic Class Miscellaneous Antibiotics
Manufacturer
Available Country Chile
Last Updated: September 19, 2023 at 7:00 am
Ribolac
Ribolac

Uses

Acute infectious diarrhoea including travelers diarrhoea, Diarrhoea predominant Irritable Bowel Syndrome (IBS-D), Hepatic Encephalopathy (H.E.)

Ribolac is also used to associated treatment for these conditions: Bacterial Infections, Clostridium difficile infection recurrence, Hepatic Encephalopathy (HE), Irritable Bowel Syndrome (IBS), Traveler's Diarrhea

How Ribolac works

Ribolac acts by inhibiting RNA synthesis in susceptible bacteria by binding to the beta-subunit of bacterial deoxyribonucleic acid (DNA)-dependent ribonucleic acid (RNA) polymerase enzyme. This binding blocks translocation, which stops transcription.

Dosage

Ribolac dosage

Acute Infectious Diarrhoea including Travelers’ Diarrhoea: 200 mg three times daily for 3 days.

Diarrhoea predominant Irritable Bowel Syndrome (IBS-D): 550 mg three times daily for 14 days.

Hepatic Encephalopathy (H.E.): 550 mg twice daily

Side Effects

Common side effects are nausea, vomiting, abdominal pain, flatulence, headache and dizziness.

Toxicity

LD50 > 2 g/kg (orally, in rats)

Precaution

Pregnancy and lactation. Caution in severe hepatic impairment (Child-Pugh class C). Not effective against diarrhoea caused by pathogen other than E. coli ; or diarrhoea complicated by fever and/or blood in the stool. Prolonged use may result in Clotridum difficile-associated diarrhoea. Severe hepatic impairment (Child-pugh class C).

Interaction

Although In vitro studies demonstrated the potential of Ribolac to interact with cytochrome P450 (CYP3A4), a clinical drug-drug interaction study demonstrated that Ribolac did not significantly affect the pharmacokinetics of midazolam. An additional clinical drug-drug interaction study showed no effect of Ribolac on the presystemic metabolism of an oral contraceptive containing ethinyl estradiol and norgestimate. Therefore, clinical interactions with drugs metabolized by human cytochrome P450 isozymes are not expected.

Food Interaction

  • Take with or without food. Fatty meals may increase the systemic AUC of rifaximin, but do not impact Cmax. Ribolac is an antibacterial used for local action in the gastrointestinal tract; therefore, changes in systemic exposure may not significantly impact efficacy.

Elimination Route

Low absorption in both the fasting state and when administered within 30 minutes of a high-fat breakfast.

Half Life

Approximately 6 hours.

Elimination Route

In a mass balance study, after administration of 400 mg 14C-rifaximin orally to healthy volunteers, of the 96.94% total recovery, 96.62% of the administered radioactivity was recovered in feces almost exclusively as the unchanged drug and 0.32% was recovered in urine mostly as metabolites with 0.03% as the unchanged drug.Ribolac accounted for 18% of radioactivity in plasma. This suggests that the absorbed rifaximin undergoes metabolism with minimal renal excretion of the unchanged drug

Pregnancy & Breastfeeding use

Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Ribolac should be used during pregnancy only if the potential benefit outweighs the potential risk to the fetus.

Use in Lactation: It is not known whether Ribolac is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for adverse reactions in nursing infants from Ribolac, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Contraindication

Ribolac is contraindicated in patients with a hypersensitivity to Ribolac, or any of the Rifamycin antimicrobial agents, or any of the components of Ribolac.

Special Warning

Use in Children: The safety and effectiveness of Ribolac 200 mg in pediatric patients with travelers’ diarrhoea less than 12 years of age have not established.The safety and effectiveness of Ribolac 550 mg for hepatic encephalopathy have not been established in patients <18 years of age.

Use in geriatric patients: Clinical studies of Ribolac tablets did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently than younger subjects.

Use in Renal Insufficient Patients:The pharmacokinetics of Ribolac in patients with impaired renal function has not been studied.

Use in Hepatic Insufficient Patients:No dosage adjustment with Ribolac is necessary due to its limited systemic absorption. Nonetheless, caution should be exercised when Ribolac is administered to patients with severe hepatic impairment.

Acute Overdose

No specific information is available on the treatment of over dosage with Ribolac. In case of over dosage, discontinue Ribolac, treat symptomatically and institute supportive measures as required.

Storage Condition

Store at 20-25° C; excursions permitted to 15-30° C.

Innovators Monograph

You find simplified version here Ribolac

Ribolac contains Rifaximin see full prescribing information from innovator Ribolac Monograph, Ribolac MSDS, Ribolac FDA label

FAQ

What is Ribolac used for?

Ribolac is used to treat traveler's diarrhea that is caused by a bacteria called Escherichia coli. It is also used to prevent hepatic encephalopathy, which is a condition that occurs when your liver does not work normally.Ribolac is also used to treat irritable bowel syndrome with diarrhea.

How safe is Ribolac?

Ribolac is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy.

How does Ribolac work?

Ribolac treats traveler's diarrhea and irritable bowel syndrome by stopping the growth of the bacteria that cause diarrhea. Ribolac treats hepatic encephalopathy by stopping the growth of bacteria that produce toxins and that may worsen liver disease.

What are the common side effects of Ribolac?

Common side effects of Ribolac are include:

  • Gas (flatulence)
  • Headache
  • Feeling as if your bowels are not completely emptied
  • Feeling you need to urgently empty your bowels
  • Abdominal or stomach pain
  • Nausea
  • Constipation
  • Fever
  • Vomiting
  • Bloating
  • Dizziness
  • Tired feeling
  • Swelling in your hands, feet, or torso

Is Ribolac safe during pregnancy?

There are no adequate and well controlled studies in pregnant women.Ribolac tablets should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Is Ribolac safe during breastfeeding?

Ribolac is poorly absorbed orally and used only for gastrointestinal infections. It is not likely to reach the breastmilk or bloodstream of the infant or cause any adverse effects in breastfed infants after maternal use.

When Is the best taken of Ribolac?

Ribolac usually 2 times a day (every 12 hours).Take this medication at the same time(s) every day.

Can I take Ribolac on an empty stomach?

Ribolac should be taken on an empty stomach.

Should Ribolac be taken with food?

You may take this medicine with or without food.

Is Ribolac strong antibiotic?

Ribolac is a gastrointestinal-selective antibiotic with a broad spectrum of antimicrobial activity, an excellent safety profile, minimal drug interactions, and negligible impact on the intestinal microbiome.

How fast does Ribolac work?

After just two weeks of treatment, relief lasted for up to 6 months.

Who should not take Ribolac?

You should not take Ribolac if you are allergic to Ribolac. Tell your doctor if you have ever had.Tell your doctor if you are pregnant or breastfeeding.Ribolac should not be given to a child younger than 12 years old.

Is Ribolac safe for liver?

Ribolac could theoretically prevent SBP in patients with liver cirrhosis by reducing gut bacteria.

Can Ribolac help constipation?

The antibiotic Ribolac is used to treat non-constipated irritable bowel syndrome (IBS).

How long can I take Ribolac?

You may take Ribolac with or without food. For travelers' diarrhea, Ribolac is usually taken for only 3 days.

Is Ribolac safe for kidneys?

While the effects of Ribolac have been shown to be protective against acute kidney injury  and hepatorenal syndrome in alcohol-induced cirrhosis, its long-term effects on the renal function of other cirrhotic patients are unknown.

What happens if I miss a dose of Ribolac?

Take Ribolac as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not take two doses at one time.

What should I avoid while taking Ribolac?

Antibiotic medicines can cause diarrhea, which may be a sign of a new infection. If you have diarrhea that is watery or bloody, call your doctor before using anti-diarrhea medicine.

How many Ribolac can Ribolac take in a day?

Adults and children 12 years of age and older 200 milligrams (mg) three times a day for 3 days. Children younger than 12 years of age.Use and dose must be determined by your doctor.

*** Taking medicines without doctor's advice can cause long-term problems.
Share